Persistent paradox of natural history of human T lymphotropic virus type I: Parallel analyses of Japanese and Jamaican carriers

Journal of Infectious Diseases

Volumn 190, Issue 9, 2004, Pages 1605-1609

  Hisada, Michie ^a   Stuver, Sherri O ^b,c   Okayama, Akihiko ^d   Li, Hong Chuan ^a   Sawada, Takashi ^e   Hanchard, Barrie ^f   Mueller, Nancy E ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MIYAZAKI   (Japan)

^e EISAI CO LTD   (Japan)

^f UNIVERSITY OF THE WEST INDIES   (Jamaica)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE RESPONSE; JAMAICA; JAPAN; MALE; PATHOGENESIS; PRIORITY JOURNAL; VIRUS CARRIER; VIRUS LOAD;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CARRIER STATE; FEMALE; GENE PRODUCTS, TAX; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; JAMAICA; JAPAN; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PROVIRUSES; VIREMIA;

EID: 6944230899     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/424598     Document Type: Article

References (14)

1. Manns A, Hisada M, La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999; 353:1951-8.
2. Mueller NE, Blattner WA. Retroviruses - human T-cell lymphotropic virus. In: Evans AS, Kaslow RA, eds. Viral infections of humans. New York, London: Plenum Medical, 1997:785-814.
3. Johnson JM, Harrod R, Franchini G. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus type-1 (HTLV-1). Int J Exp Pathol 2001; 82:135-47.
4. Yokota T, Cho MJ, Tachibana N, et al. The prevalence of antibody to p42 of HTLV-I among ATLL patients in comparison with healthy carriers in Japan. Int J Cancer 1989; 43:970-4.
5. Mueller N, Okayama A, Stuver S, Tachibana N. Findings from the Miyazaki cohort study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13(Suppl 1):S2-7.
6. Wattel E, Vartanian J-P, Pannetier C, Wain-Hobson S. Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy. J Virol 1995; 69:2863-8.
7. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 1997; 57:4862-7.
8. + cells in HTLV type 1-associated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load. AIDS Res Hum Retroviruses 2000; 16:1705-9.
9. + cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load. J Infect Dis 2001; 183:197-205.
10. Mueller NE, Birmann B, Parsonnet J, Schiffman M, Stuver S. Infectious agents. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. 3rd ed. (in press).
11. VanVeldhuisen PC, Walters M, Sawada T, et al. Seroincidence of HTLV-I infection and characterization of seroconverters in Jamaican food handlers. J Acquir Immune Defic Syndr 2003; 33:387-92.
12. Hisada M, Okayama A, Shioiro S, Spiegelman DL, Stuver SO, Mueller NE. Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. Blood 1998; 92:3557-61.
13. Tachibana N, Okayama A, Ishihara S, et al. High HTLV-I proviral DNA level associated with abnormal lymphocytes in peripheral blood from asymptomatic carriers. Int J Cancer 1992; 51:593-5.
14. Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-I associated leukemogenesis in vivo. Leukemia 2003; 17:26-38.